Baillie Gifford & Co. lowered its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 20.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,166 shares of the semiconductor company's stock after selling 5,454 shares during the quarter. Baillie Gifford & Co.'s holdings in Synopsys were worth $9,942,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also bought and sold shares of SNPS. Vanguard Group Inc. lifted its position in Synopsys by 20.7% during the third quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company's stock valued at $8,970,415,000 after purchasing an additional 3,120,401 shares during the last quarter. Victory Capital Management Inc. raised its stake in shares of Synopsys by 238.8% in the third quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company's stock valued at $1,393,506,000 after acquiring an additional 1,990,608 shares during the period. Coatue Management LLC purchased a new stake in shares of Synopsys in the third quarter valued at $892,605,000. Capital Research Global Investors raised its stake in shares of Synopsys by 226.6% in the third quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company's stock valued at $1,245,533,000 after acquiring an additional 1,751,432 shares during the period. Finally, State Street Corp raised its stake in shares of Synopsys by 20.6% in the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company's stock valued at $4,322,273,000 after acquiring an additional 1,493,912 shares during the period. Institutional investors own 85.47% of the company's stock.
Analyst Ratings Changes
SNPS has been the topic of several recent analyst reports. HSBC downgraded shares of Synopsys from a "buy" rating to a "hold" rating and set a $455.00 target price on the stock. in a research note on Friday, February 20th. Rosenblatt Securities reduced their target price on shares of Synopsys from $560.00 to $530.00 and set a "buy" rating on the stock in a research note on Thursday, February 26th. Morgan Stanley reissued an "equal weight" rating and issued a $480.00 target price (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. Needham & Company LLC reissued a "buy" rating on shares of Synopsys in a research note on Thursday, February 26th. Finally, Wells Fargo & Company reduced their target price on shares of Synopsys from $500.00 to $450.00 and set an "equal weight" rating on the stock in a research note on Thursday, February 26th. Eight analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Synopsys has an average rating of "Hold" and an average price target of $531.00.
Get Our Latest Stock Report on Synopsys
Synopsys Trading Up 6.5%
SNPS stock opened at $417.77 on Tuesday. The company has a market capitalization of $80.03 billion, a PE ratio of 64.87, a P/E/G ratio of 3.20 and a beta of 1.15. Synopsys, Inc. has a 12 month low of $376.18 and a 12 month high of $651.73. The firm's 50-day moving average is $420.80 and its 200 day moving average is $446.38. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26.
Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping the consensus estimate of $3.56 by $0.21. The company had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The firm's revenue was up 65.6% compared to the same quarter last year. During the same quarter last year, the firm posted $3.03 EPS. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, research analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.
Synopsys Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.